|
Delayed
OTC Markets
20:08:39 04/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.007600 USD | +1.33% |
|
+1.33% | -20.00% |
| 08-15 | Evofem Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-01 | HUB Cyber Security Acquires Evofem Notes, Cuts Staff | MT |
| Market Cap | 994K 855K 805K 735K 1.38M 93.85M 1.38M 9.51M 3.69M 48.15M 3.73M 3.65M 155M | P/E 2024 |
-0.08x | P/E 2025 | 26.7x |
|---|---|---|---|---|---|
| Enterprise Value | 55.41M 47.68M 44.86M 40.98M 76.66M 5.23B 76.87M 530M 206M 2.68B 208M 204M 8.65B | EV / Sales 2024 |
2.43x | EV / Sales 2025 | 2.76x |
| Free-Float |
100% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.33% | ||
| 1 week | +1.33% | ||
| Current month | -7.88% | ||
| 1 month | +5.92% | ||
| 3 months | -10.59% | ||
| 6 months | -16.48% | ||
| Current year | -20.00% |
| 1 week | 0.01 |  | 0.01 |
| 1 month | 0.01 | | 0.01 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.02 |
| 3 years | 0 | | 0.25 |
| 5 years | 0 | | 1,774.5 |
| 10 years | 0 | | 23,549.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 01/01/2018 | |
Ivy Zhang
DFI | Director of Finance/CFO | 49 | 13/04/2023 |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | - | |
Colin Rutherford
BRD | Director/Board Member | 67 | 01/01/2018 |
Kim Kamdar
BRD | Director/Board Member | 58 | 01/01/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/01/24 | Sell | Chief Financial Officer | 104 | 0.0010% | ||
| 21/12/23 | Sell | Director | 10 | 0.0001% | ||
| 13/04/23 | Other | Chief Financial Officer | 13,000 | 0.0107% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.33% | +1.33% | -19.15% | -96.00% | 994K | |
| -1.41% | -2.83% | +53.63% | +104.47% | 1,034B | |
| -1.05% | +2.80% | +54.14% | +71.48% | 671B | |
| -1.44% | +0.30% | +20.31% | +75.39% | 460B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 353B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 309B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 255B | |
| -1.59% | +1.01% | +55.94% | +71.96% | 240B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 207B | |
| -0.47% | +3.21% | +33.32% | +100.04% | 188B | |
| Average | -0.76% | +0.29% | +23.38% | +36.94% | 371.68B | |
| Weighted average by Cap. | -1.10% | +1.04% | +36.29% | +66.24% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 19.36M 16.66M 15.68M 14.32M 26.79M 1.83B 26.86M 185M 71.88M 938M 72.71M 71.12M 3.02B | 20.18M 17.37M 16.34M 14.93M 27.92M 1.91B 28M 193M 74.93M 978M 75.79M 74.14M 3.15B |
| Net income | -8.86M -7.62M -7.17M -6.55M -12.26M -837M -12.29M -84.76M -32.89M -429M -33.27M -32.54M -1.38B | 391K 336K 317K 289K 541K 36.92M 542K 3.74M 1.45M 18.94M 1.47M 1.44M 61.02M |
| Net Debt | 45.84M 39.45M 37.11M 33.9M 63.42M 4.33B 63.59M 439M 170M 2.22B 172M 168M 7.15B | 54.42M 46.83M 44.06M 40.25M 75.29M 5.14B 75.49M 521M 202M 2.64B 204M 200M 8.49B |
Employees
29
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | $0.007600 | +1.33% | 51,912 |
| 03/09/26 | $0.007500 | -6.25% | 264,387 |
| 02/09/26 | $0.008000 | 0.00% | 231,890 |
| 01/09/26 | $0.008000 | -3.03% | 190,649 |
| 31/08/26 | $0.008250 | +10.00% | 67,052 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- EVFM Stock
Select your edition
All financial news and data tailored to specific country editions
